2014 Q2 Form 10-Q Financial Statement
#000110465914031463 Filed on April 29, 2014
Income Statement
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q4 |
|---|---|---|---|
| Revenue | $322.8M | $289.4M | $289.0M |
| YoY Change | 15.04% | 18.06% | 18.54% |
| Cost Of Revenue | $38.70M | $30.60M | $38.80M |
| YoY Change | 19.74% | 4.39% | 2.92% |
| Gross Profit | $284.1M | $254.3M | $247.5M |
| YoY Change | 15.88% | 18.92% | 22.07% |
| Gross Profit Margin | 88.01% | 87.86% | 85.64% |
| Selling, General & Admin | $68.00M | $30.22M | $157.2M |
| YoY Change | -4.76% | -57.66% | 292.02% |
| % of Gross Profit | 23.94% | 11.88% | 63.51% |
| Research & Development | $39.70M | $12.45M | $121.6M |
| YoY Change | -27.29% | -75.32% | 224.27% |
| % of Gross Profit | 13.97% | 4.9% | 49.13% |
| Depreciation & Amortization | $7.600M | $7.565M | $7.800M |
| YoY Change | 0.0% | -7.35% | 8.33% |
| % of Gross Profit | 2.68% | 2.98% | 3.15% |
| Operating Expenses | $107.8M | $42.66M | $278.7M |
| YoY Change | -14.44% | -64.97% | 259.61% |
| Operating Profit | $176.3M | $216.1M | -$31.18M |
| YoY Change | 44.15% | 129.85% | -124.89% |
| Interest Expense | -$3.600M | $4.610M | -$3.500M |
| YoY Change | -179.65% | 3.92% | -7.89% |
| % of Operating Profit | -2.04% | 2.13% | |
| Other Income/Expense, Net | $300.0K | -$2.924M | $300.0K |
| YoY Change | -107.93% | -8.68% | 200.0% |
| Pretax Income | $173.0M | $213.2M | -$31.60M |
| YoY Change | 45.97% | 134.73% | -125.28% |
| Income Tax | $61.20M | $75.69M | -$1.300M |
| % Of Pretax Income | 35.38% | 35.5% | |
| Net Earnings | $111.9M | $137.5M | -$30.30M |
| YoY Change | 40.05% | 120.71% | -136.37% |
| Net Earnings / Revenue | 34.67% | 47.51% | -10.48% |
| Basic Earnings Per Share | -$0.60 | ||
| Diluted Earnings Per Share | $2.099M | $2.425M | -$0.60 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 48.18M shares | 50.40M shares | 50.23M shares |
| Diluted Shares Outstanding | 56.66M shares |
Balance Sheet
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $567.6M | $760.5M | $693.9M |
| YoY Change | -18.52% | 13.41% | 44.8% |
| Cash & Equivalents | $259.0M | $413.8M | $278.9M |
| Short-Term Investments | $308.5M | $346.7M | $409.6M |
| Other Short-Term Assets | $43.10M | $46.29M | $46.42M |
| YoY Change | 40.39% | 692.87% | 31.2% |
| Inventory | $58.00M | $51.72M | $47.76M |
| Prepaid Expenses | |||
| Receivables | $212.9M | $131.8M | $126.3M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $881.6M | $990.3M | $909.0M |
| YoY Change | -2.43% | 17.25% | 35.98% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $477.5M | $474.4M | $465.0M |
| YoY Change | 6.61% | 5.64% | 2.48% |
| Goodwill | $10.70M | $10.70M | |
| YoY Change | 2.84% | 1.64% | |
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | $280.9M | $384.1M | $448.1M |
| YoY Change | 41.8% | 86.37% | 46.58% |
| Other Assets | $297.5M | $53.08M | $53.27M |
| YoY Change | 39.54% | 99.56% | 98.89% |
| Total Long-Term Assets | $1.071B | $1.125B | $1.179B |
| YoY Change | 22.56% | 31.88% | 23.01% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $881.6M | $990.3M | $909.0M |
| Total Long-Term Assets | $1.071B | $1.125B | $1.179B |
| Total Assets | $1.953B | $2.115B | $2.088B |
| YoY Change | 9.86% | 24.6% | 28.34% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $112.2M | $104.0M | $6.708M |
| YoY Change | 1093.62% | 920.21% | -34.25% |
| Accrued Expenses | $85.54M | ||
| YoY Change | 17.2% | ||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $363.3M | $285.4M | $282.5M |
| YoY Change | 72.84% | 21630.77% | |
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $659.1M | $658.5M | $687.7M |
| YoY Change | 59.89% | 272.89% | 289.05% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $3.700M | $0.00 |
| YoY Change | -100.0% | -98.67% | -100.0% |
| Other Long-Term Liabilities | $80.70M | $95.01M | $91.86M |
| YoY Change | 2.15% | 16.62% | 14.87% |
| Total Long-Term Liabilities | $80.70M | $95.01M | $91.86M |
| YoY Change | -45.95% | 16.62% | 14.87% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $659.1M | $658.5M | $687.7M |
| Total Long-Term Liabilities | $80.70M | $95.01M | $91.86M |
| Total Liabilities | $739.8M | $757.2M | $783.3M |
| YoY Change | 31.75% | 41.34% | 47.3% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $865.6M | $728.0M | |
| YoY Change | 40.56% | 31.54% | |
| Common Stock | $1.077B | $1.058B | |
| YoY Change | 4.66% | 4.07% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $611.1M | $513.4M | |
| YoY Change | 28.13% | 9.01% | |
| Treasury Stock Shares | 13.65M shares | 12.63M shares | |
| Shareholders Equity | $1.213B | $1.316B | $1.259B |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $1.953B | $2.115B | $2.088B |
| YoY Change | 9.86% | 24.6% | 28.34% |
Cashflow Statement
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $111.9M | $137.5M | -$30.30M |
| YoY Change | 40.05% | 120.71% | -136.37% |
| Depreciation, Depletion And Amortization | $7.600M | $7.565M | $7.800M |
| YoY Change | 0.0% | -7.35% | 8.33% |
| Cash From Operating Activities | -$54.50M | $110.6M | $104.5M |
| YoY Change | -165.04% | 13.2% | -0.67% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$12.80M | $18.68M | -$13.40M |
| YoY Change | 161.22% | 340.16% | -36.79% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $95.00M | $125.1M | -$143.0M |
| YoY Change | 202.55% | 739.6% | -0.35% |
| Cash From Investing Activities | $82.20M | $106.4M | -$156.4M |
| YoY Change | 209.02% | 903.77% | -5.04% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $97.63M | ||
| YoY Change | 1553.68% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -182.8M | -81.90M | 8.900M |
| YoY Change | 528.18% | -11800.0% | -117.84% |
| NET CHANGE | |||
| Cash From Operating Activities | -54.50M | 110.6M | 104.5M |
| Cash From Investing Activities | 82.20M | 106.4M | -156.4M |
| Cash From Financing Activities | -182.8M | -81.90M | 8.900M |
| Net Change In Cash | -155.1M | 135.1M | -43.00M |
| YoY Change | -290.77% | 23.94% | -60.69% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$54.50M | $110.6M | $104.5M |
| Capital Expenditures | -$12.80M | $18.68M | -$13.40M |
| Free Cash Flow | -$41.70M | $91.92M | $117.9M |
| YoY Change | -147.01% | -1.64% | -6.72% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014Q1 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
-226000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-2458000 | USD |
| CY2014Q1 | uthr |
Estimated Annual Effective Income Tax Rate
EstimatedAnnualEffectiveIncomeTaxRate
|
0.35 | pure |
| CY2013Q1 | uthr |
Estimated Annual Effective Income Tax Rate
EstimatedAnnualEffectiveIncomeTaxRate
|
0.34 | pure |
| CY2014Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment |
| CY2014Q1 | uthr |
Commercial Products Number
CommercialProductsNumber
|
3 | item |
| CY2013Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
243146000 | USD |
| CY2014Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
284553000 | USD |
| CY2013Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
29313000 | USD |
| CY2013Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
11802000 | USD |
| CY2014Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
12728000 | USD |
| CY2013Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
17579000 | USD |
| CY2014Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
19807000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Before Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
|
309000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
|
-199000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
|
-52000 | USD |
| CY2013Q1 | uthr |
Cost Of Revenues
CostOfRevenues
|
29313000 | USD |
| CY2014Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
30600000 | USD |
| CY2013Q1 | us-gaap |
Gross Profit
GrossProfit
|
213833000 | USD |
| CY2014Q1 | us-gaap |
Gross Profit
GrossProfit
|
254280000 | USD |
| CY2014Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">1. Organization and Business Description</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. As used in these notes to the consolidated financial statements, unless the context otherwise requires, the terms “we”, “us”, “our,” and similar terms refer to United Therapeutics Corporation and its consolidated subsidiaries.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">We have approval from the United States Food and Drug Administration (FDA) to market the following therapies: Remodulin</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">®</font><font style="FONT-SIZE: 10pt;" size="2"> (treprostinil) Injection (Remodulin), Tyvaso</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">®</font><font style="FONT-SIZE: 10pt;" size="2"> (treprostinil) Inhalation Solution (Tyvaso), Adcirca</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">®</font><font style="FONT-SIZE: 10pt;" size="2"> (tadalafil) Tablets (Adcirca) and Orenitram™ (treprostinil) Extended-Release Tablets (Orenitram). We commenced commercial sales of Orenitram in the United States in April 2014. Remodulin has also been approved in various countries outside the United States.</font></p> </div> | |
| CY2014Q1 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">2. Basis of Presentation</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The accompanying unaudited consolidated financial statements have been prepared in accordance with the rules and regulations of the United States Securities and Exchange Commission (SEC) for interim financial information. Accordingly, they do not include all of the information required by United States generally accepted accounting principles (GAAP) for complete financial statements. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the accompanying notes to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the SEC on February 25, 2014.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In our management’s opinion, the accompanying consolidated financial statements contain all adjustments, including normal, recurring adjustments, necessary to fairly present our financial position as of March 31, 2014, results of operations and comprehensive income for the three-month periods ended March 31, 2014 and 2013, and cash flows for the three-month periods ended March 31, 2014 and 2013. Interim results are not necessarily indicative of results for an entire year.</font></p> </div> | |
| CY2013Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
18377000 | USD |
| CY2014Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
19182000 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
47758000 | USD |
| CY2014Q1 | us-gaap |
Inventory Net
InventoryNet
|
51717000 | USD |
| CY2013Q4 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
857394000 | USD |
| CY2014Q1 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
730465000 | USD |
| CY2013Q4 | uthr |
Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
|
557000 | USD |
| CY2014Q1 | uthr |
Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
|
806000 | USD |
| CY2013Q4 | uthr |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
240000 | USD |
| CY2014Q1 | uthr |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
194000 | USD |
| CY2013Q4 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
857711000 | USD |
| CY2014Q1 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
731077000 | USD |
| CY2013Q4 | us-gaap |
Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
|
409645000 | USD |
| CY2014Q1 | us-gaap |
Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
|
346698000 | USD |
| CY2013Q4 | us-gaap |
Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
|
447749000 | USD |
| CY2014Q1 | us-gaap |
Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
|
383767000 | USD |
| CY2013Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
|
245320000 | USD |
| CY2014Q1 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
|
179681000 | USD |
| CY2014Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
346698000 | USD |
| CY2014Q1 | uthr |
Held To Maturity Securities Debt Maturities In One Year Through Two Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesInOneYearThroughTwoYearsNetCarryingAmount
|
246705000 | USD |
| CY2014Q1 | uthr |
Held To Maturity Securities Debt Maturities In Three Year Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesInThreeYearThroughFiveYearsNetCarryingAmount
|
137062000 | USD |
| CY2014Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
346868000 | USD |
| CY2014Q1 | uthr |
Held To Maturity Securities Debt Maturities In One Year Through Two Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesInOneYearThroughTwoYearsFairValue
|
247037000 | USD |
| CY2014Q1 | uthr |
Held To Maturity Securities Debt Maturities In Three Year Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesInThreeYearThroughFiveYearsFairValue
|
137172000 | USD |
| CY2013Q4 | us-gaap |
Goodwill Gross
GoodwillGross
|
10703000 | USD |
| CY2014Q1 | us-gaap |
Goodwill Gross
GoodwillGross
|
10699000 | USD |
| CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
10703000 | USD |
| CY2014Q1 | us-gaap |
Goodwill
Goodwill
|
10699000 | USD |
| CY2014Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
474410000 | USD |
| CY2013Q4 | uthr |
Goodwill And Other Intangibles Assets Gross
GoodwillAndOtherIntangiblesAssetsGross
|
22719000 | USD |
| CY2014Q1 | uthr |
Goodwill And Other Intangibles Assets Gross
GoodwillAndOtherIntangiblesAssetsGross
|
22705000 | USD |
| CY2013Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
14115000 | USD |
| CY2014Q1 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
13737000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
8604000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
8968000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Before Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
|
207000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
|
406000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
|
361000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
|
136000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
|
126000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
|
270000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
|
235000 | USD |
| CY2013Q1 | us-gaap |
Interest Costs Incurred
InterestCostsIncurred
|
4436000 | USD |
| CY2014Q1 | us-gaap |
Interest Costs Incurred
InterestCostsIncurred
|
4610000 | USD |
| CY2013Q1 | us-gaap |
Interest Expense
InterestExpense
|
4436000 | USD |
| CY2014Q1 | us-gaap |
Interest Expense
InterestExpense
|
4610000 | USD |
| CY2014Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
42143000 | USD |
| CY2013Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
45037000 | USD |
| CY2013Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
62325000 | USD |
| CY2014Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
137524000 | USD |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
50209000 | shares |
| CY2014Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
50402000 | shares |
| CY2013Q1 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
826000 | shares |
| CY2014Q1 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
2798000 | shares |
| CY2014Q1 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
1780000 | shares |
| CY2013Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1341000 | shares |
| CY2014Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1677000 | shares |
| CY2014Q1 | us-gaap |
Revenues
Revenues
|
289403000 | USD |
| CY2014Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
56657000 | shares |
| CY2013Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.19 | |
| CY2014Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
271242 | shares |
| CY2014Q1 | us-gaap |
Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
|
8434000 | USD |
| CY2013Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
149367 | shares |
| CY2013Q1 | us-gaap |
Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
|
4258000 | USD |
| CY2014Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-15641000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-13183000 | USD |
| CY2014Q1 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
4850000 | USD |
| CY2014Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
12448000 | USD |
| CY2014Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
30215000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
-2684000 | USD |
| CY2014Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1232000 | USD |
| CY2014Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
UNITED THERAPEUTICS Corp | |
| CY2014Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001082554 | |
| CY2014Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2014Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-03-31 | |
| CY2014Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2014Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2014Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | |
| CY2014Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
48176159 | shares |
| CY2014Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
278889000 | USD |
| CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
126297000 | USD |
| CY2013Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
46424000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
909013000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
92244000 | USD |
| CY2013Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
215845000 | USD |
| CY2013Q4 | uthr |
Share Tracking Award Plans
ShareTrackingAwardPlans
|
287956000 | USD |
| CY2013Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
448134000 | USD |
| CY2013Q4 | us-gaap |
Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
|
5369000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
464950000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
192718000 | USD |
| CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
53268000 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
2087567000 | USD |
| CY2013Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
66614000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
25015000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
687674000 | USD |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
630000 | USD |
| CY2013Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
3724000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
91858000 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
783256000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1057224000 | USD |
| CY2013Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
513437000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
728040000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1259274000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2087567000 | USD |
| CY2014Q1 | us-gaap |
Assets
Assets
|
2114934000 | USD |
| CY2014Q1 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
3700000 | USD |
| CY2014Q1 | us-gaap |
Assets Current
AssetsCurrent
|
990268000 | USD |
| CY2014Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
658535000 | USD |
| CY2014Q1 | us-gaap |
Liabilities
Liabilities
|
757244000 | USD |
| CY2014Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1315547000 | USD |
| CY2014Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2114934000 | USD |
| CY2014Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
0 | USD |
| CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
0 | USD |
| CY2014Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
245000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
245000000 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
63310968 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
63013192 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
49658547 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
50388140 | shares |
| CY2014Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
13652421 | shares |
| CY2013Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
12625052 | shares |
| CY2013Q1 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
1990000 | USD |
| CY2013Q1 | us-gaap |
Revenues
Revenues
|
245136000 | USD |
| CY2013Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
50430000 | USD |
| CY2013Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
71356000 | USD |
| CY2013Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
151099000 | USD |
| CY2013Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
979000 | USD |
| CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
94037000 | USD |
| CY2013Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
255000 | USD |
| CY2013Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-3202000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
90835000 | USD |
| CY2013Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
28510000 | USD |
| CY2014Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
73263000 | USD |
| CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
216140000 | USD |
| CY2014Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2924000 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
213216000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-2290000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
|
51000 | USD |
| CY2013Q1 | uthr |
Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
|
256000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
-307000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-23000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-2006000 | USD |
| CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
60319000 | USD |
| CY2014Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
135066000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
|
2415000 | USD |
| CY2013Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8165000 | USD |
| CY2013Q1 | uthr |
Provision For Doubtful Accounts And Inventory Writedown
ProvisionForDoubtfulAccountsAndInventoryWritedown
|
-188000 | USD |
| CY2013Q1 | uthr |
Income Tax Cash Flows
IncomeTaxCashFlows
|
28510000 | USD |
| CY2013Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
35213000 | USD |
| CY2013Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
3083000 | USD |
| CY2013Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-1006000 | USD |
| CY2013Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-311000 | USD |
| CY2013Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
962000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-15030000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
2559000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-3162000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-3915000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-51483000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
110597000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
97698000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4243000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
111745000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
126623000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
10635000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
106379000 | USD |
| CY2013Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
5904000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
4258000 | USD |
| CY2014Q1 | uthr |
Income Tax Cash Flows
IncomeTaxCashFlows
|
75692000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
-60723000 | USD |
| CY2014Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
3265000 | USD |
| CY2014Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-1604000 | USD |
| CY2014Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-199000 | USD |
| CY2014Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
6907000 | USD |
| CY2014Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
46288000 | USD |
| CY2014Q1 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
384140000 | USD |
| CY2014Q1 | us-gaap |
Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
|
5393000 | USD |
| CY2014Q1 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
193910000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
|
1378000 | USD |
| CY2013Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
962000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
694000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-81917000 | USD |
| CY2013Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-931000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
108096000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
134905000 | USD |
| CY2013Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2031000 | USD |
| CY2013Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
44949000 | USD |
| CY2013Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
799000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
413794000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
262126000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
154030000 | USD |
| CY2013Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
11026000 | shares |
| CY2014Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9705000 | shares |
| CY2014Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
131771000 | USD |
| CY2014Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
454000 | USD |
| CY2014Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
75692000 | USD |
| CY2014Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7565000 | USD |
| CY2014Q1 | uthr |
Provision For Doubtful Accounts And Inventory Writedown
ProvisionForDoubtfulAccountsAndInventoryWritedown
|
459000 | USD |
| CY2014Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
5606000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
5913000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
4799000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-500000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
11724000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-50894000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
18676000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
110070000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
235125000 | USD |
| CY2014Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
97633000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
8376000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
|
1734000 | USD |
| CY2014Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
5606000 | USD |
| CY2014Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-154000 | USD |
| CY2014Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1971000 | USD |
| CY2014Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
66803000 | USD |
| CY2014Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
53076000 | USD |
| CY2014Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
104015000 | USD |
| CY2014Q1 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
218739000 | USD |
| CY2014Q1 | uthr |
Share Tracking Award Plans
ShareTrackingAwardPlans
|
207786000 | USD |
| CY2014Q1 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
66614000 | USD |
| CY2014Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
61381000 | USD |
| CY2014Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
95009000 | USD |
| CY2014Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
633000 | USD |
| CY2014Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1076061000 | USD |
| CY2014Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
611070000 | USD |
| CY2014Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
865564000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-477000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
|
221000 | USD |
| CY2014Q1 | uthr |
Other Comprehensive Income Loss Amortization Gain Loss And Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeLossAmortizationGainLossAndNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
|
226000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
1968000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-13000 | USD |
| CY2014Q1 | uthr |
Cost Of Revenues
CostOfRevenues
|
30273000 | USD |
